These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 17351376

  • 1. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
    Rubattu S, Sciarretta S, Ciavarella GM, Venturelli V, De Paolis P, Tocci G, De Biase L, Ferrucci A, Volpe M.
    J Hypertens; 2007 Apr; 25(4):833-9. PubMed ID: 17351376
    [Abstract] [Full Text] [Related]

  • 2. Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome.
    Sciarretta S, Ferrucci A, Ciavarella GM, De Paolis P, Venturelli V, Tocci G, De Biase L, Rubattu S, Volpe M.
    Am J Hypertens; 2007 Jul; 20(7):784-91. PubMed ID: 17586414
    [Abstract] [Full Text] [Related]

  • 3. Natriuretic peptides in patients with aortic stenosis.
    Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjørnerheim R, Endresen K, Hall C.
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [Abstract] [Full Text] [Related]

  • 4. N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension.
    Partanen N, Husso M, Vuolteenaho O, Sipola P, Ruskoaho H, Peuhkurinen K, Magga J.
    J Hum Hypertens; 2011 Dec; 25(12):746-51. PubMed ID: 21248782
    [Abstract] [Full Text] [Related]

  • 5. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
    Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M, Kurihara N, Takeda T.
    Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
    [Abstract] [Full Text] [Related]

  • 6. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.
    Almeida P, Azevedo A, Rodrigues R, Dias P, Friões F, Vazquez B, Abreu-Lima C, Bettencourt P, Barros H.
    Rev Port Cardiol; 2003 Mar; 22(3):327-36. PubMed ID: 12847875
    [Abstract] [Full Text] [Related]

  • 7. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
    Rubattu S, Barbato A, Marchitti S, Iacone R, Di Castro S, Evangelista A, Stanzione R, Ippolito R, Sciarretta S, Palmieri L, Volpe M, Strazzullo P, Olivetti Heart Study Research Group.
    J Hypertens; 2010 Aug; 28(8):1638-45. PubMed ID: 20453667
    [Abstract] [Full Text] [Related]

  • 8. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7).
    Cuspidi C, Giudici V, Negri F, Meani S, Sala C, Zanchetti A, Mancia G.
    J Hypertens; 2009 Dec; 27(12):2465-71. PubMed ID: 19898252
    [Abstract] [Full Text] [Related]

  • 9. Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects.
    Mulè G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Giandalia ME, Palermo A, Mezzatesta G, Cerasola G.
    Int J Cardiol; 2007 Oct 18; 121(3):267-75. PubMed ID: 17258825
    [Abstract] [Full Text] [Related]

  • 10. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function.
    Nishikimi T, Mori Y, Ishimura K, Tadokoro K, Yagi H, Yabe A, Horinaka S, Matsuoka H.
    Am J Med; 2004 Apr 15; 116(8):517-23. PubMed ID: 15063812
    [Abstract] [Full Text] [Related]

  • 11. Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.
    Cortés R, Otero MR, Morillas P, Roselló-Lletí E, Grigorian L, Martínez-Dolz L, de Burgos FG, Calabuig JR, Soria F, Lozano T, Portolés M, Bertomeu V.
    Am J Hypertens; 2008 Jul 15; 21(7):820-5. PubMed ID: 18443568
    [Abstract] [Full Text] [Related]

  • 12. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 13. [Atrial natriuretic peptide, left ventricular mass and renin-angiotensin-aldosterone system in essential arterial hypertension of a mild or moderate degree].
    Gambini G, Talamonti D, Valori C.
    G Ital Cardiol; 1992 Dec 13; 22(12):1397-403. PubMed ID: 1294423
    [Abstract] [Full Text] [Related]

  • 14. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
    Andersson B, Hall C.
    J Card Fail; 2000 Sep 13; 6(3):208-13. PubMed ID: 10997746
    [Abstract] [Full Text] [Related]

  • 15. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM, Laurita E, Selva E, Piantanida E, Imperiale D, Giovanella L, Guasti L, Venco A.
    Eur J Clin Invest; 2004 May 13; 34(5):342-8. PubMed ID: 15147331
    [Abstract] [Full Text] [Related]

  • 16. Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
    Melander O, Frandsen E, Magnusson M, Grubb A, Jovinge S, Groop L.
    J Intern Med; 2005 Mar 13; 257(3):281-8. PubMed ID: 15715685
    [Abstract] [Full Text] [Related]

  • 17. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
    Kartal O, Inal V, Baysan O, Sağlam K.
    Anadolu Kardiyol Derg; 2008 Oct 13; 8(5):342-6. PubMed ID: 18849224
    [Abstract] [Full Text] [Related]

  • 18. Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension.
    Ratto E, Leoncini G, Viazzi F, Bezante GP, Falqui V, Parodi A, Conti N, Tomolillo C, Deferrari G, Pontremoli R.
    J Hypertens; 2008 Feb 13; 26(2):345-50. PubMed ID: 18192849
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.